位置:首页 > 蛋白库 > PTV3B_BACSU
PTV3B_BACSU
ID   PTV3B_BACSU             Reviewed;         609 AA.
AC   P40739; Q45661;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 2.
DT   03-AUG-2022, entry version 152.
DE   RecName: Full=PTS system beta-glucoside-specific EIIBCA component;
DE   AltName: Full=EIIBCA-Bgl;
DE            Short=EII-Bgl;
DE   Includes:
DE     RecName: Full=Beta-glucoside-specific phosphotransferase enzyme IIB component;
DE              EC=2.7.1.-;
DE     AltName: Full=PTS system beta-glucoside-specific EIIB component;
DE   Includes:
DE     RecName: Full=Beta-glucoside permease IIC component;
DE     AltName: Full=PTS system beta-glucoside-specific EIIC component;
DE   Includes:
DE     RecName: Full=Beta-glucoside-specific phosphotransferase enzyme IIA component;
DE     AltName: Full=PTS system beta-glucoside-specific EIIA component;
GN   Name=bglP; OrderedLocusNames=BSU39270; ORFNames=N17C;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168 / Marburg / ATCC 6051 / DSM 10 / JCM 1465 / NBRC 13719 / NCIMB
RC   3610 / NRRL NRS-744 / VKM B-501;
RX   PubMed=7883710; DOI=10.1128/jb.177.6.1527-1535.1995;
RA   Le Coq D., Lindner C., Krueger S., Steinmetz M., Stuelke J.;
RT   "New beta-glucoside (bgl) genes in Bacillus subtilis: the bglP gene product
RT   has both transport and regulatory functions similar to those of BglF, its
RT   Escherichia coli homolog.";
RL   J. Bacteriol. 177:1527-1535(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168 / BGSC1A1;
RX   PubMed=7704263; DOI=10.1099/13500872-141-2-337;
RA   Yoshida K., Sano H., Seki S., Oda M., Fujimura M., Fujita Y.;
RT   "Cloning and sequencing of a 29 kb region of the Bacillus subtilis genome
RT   containing the hut and wapA loci.";
RL   Microbiology 141:337-343(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V.,
RA   Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R.,
RA   Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S.,
RA   Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K.,
RA   Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F.,
RA   Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D.,
RA   Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M.,
RA   Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P.,
RA   Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K.,
RA   Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S.,
RA   Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y.,
RA   Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G.,
RA   Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M.,
RA   Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y.,
RA   Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J.,
RA   Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A.,
RA   Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M.,
RA   Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S.,
RA   Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E.,
RA   Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [4]
RP   SEQUENCE REVISION TO 434.
RX   PubMed=19383706; DOI=10.1099/mic.0.027839-0;
RA   Barbe V., Cruveiller S., Kunst F., Lenoble P., Meurice G., Sekowska A.,
RA   Vallenet D., Wang T., Moszer I., Medigue C., Danchin A.;
RT   "From a consortium sequence to a unified sequence: the Bacillus subtilis
RT   168 reference genome a decade later.";
RL   Microbiology 155:1758-1775(2009).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-182.
RC   STRAIN=168;
RX   PubMed=8628237; DOI=10.1007/bf02172988;
RA   Beloin C., Hirschbein L., Le Hegarat F.;
RT   "Suppression of the Bgl+ phenotype of a delta hns strain of Escherichia
RT   coli by a Bacillus subtilis antiterminator binding site.";
RL   Mol. Gen. Genet. 250:761-766(1996).
CC   -!- FUNCTION: The phosphoenolpyruvate-dependent sugar phosphotransferase
CC       system (sugar PTS), a major carbohydrate active -transport system,
CC       catalyzes the phosphorylation of incoming sugar substrates
CC       concomitantly with their translocation across the cell membrane. This
CC       system is involved in beta-glucoside transport (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000255|PROSITE-
CC       ProRule:PRU00426}; Multi-pass membrane protein {ECO:0000255|PROSITE-
CC       ProRule:PRU00426}.
CC   -!- DOMAIN: The EIIB domain is phosphorylated by phospho-EIIA on a
CC       cysteinyl or histidyl residue, depending on the transported sugar.
CC       Then, it transfers the phosphoryl group to the sugar substrate
CC       concomitantly with the sugar uptake processed by the EIIC domain.
CC   -!- DOMAIN: The EIIC domain forms the PTS system translocation channel and
CC       contains the specific substrate-binding site.
CC   -!- DOMAIN: The EIIA domain is phosphorylated by phospho-HPr on a histidyl
CC       residue. Then, it transfers the phosphoryl group to the EIIB domain.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z34526; CAA84286.1; -; Genomic_DNA.
DR   EMBL; D31856; BAA06652.1; -; Genomic_DNA.
DR   EMBL; D29985; BAA06256.1; -; Genomic_DNA.
DR   EMBL; AL009126; CAB15963.2; -; Genomic_DNA.
DR   EMBL; X85408; CAA59697.1; -; Genomic_DNA.
DR   PIR; I40406; I40406.
DR   PIR; T47097; T47097.
DR   RefSeq; NP_391806.2; NC_000964.3.
DR   RefSeq; WP_003242943.1; NZ_JNCM01000034.1.
DR   AlphaFoldDB; P40739; -.
DR   SMR; P40739; -.
DR   STRING; 224308.BSU39270; -.
DR   TCDB; 4.A.1.2.11; the pts glucose-glucoside (glc) family.
DR   jPOST; P40739; -.
DR   PaxDb; P40739; -.
DR   PRIDE; P40739; -.
DR   EnsemblBacteria; CAB15963; CAB15963; BSU_39270.
DR   GeneID; 937518; -.
DR   KEGG; bsu:BSU39270; -.
DR   PATRIC; fig|224308.179.peg.4251; -.
DR   eggNOG; COG1263; Bacteria.
DR   eggNOG; COG1264; Bacteria.
DR   eggNOG; COG2190; Bacteria.
DR   InParanoid; P40739; -.
DR   OMA; IIMTGMH; -.
DR   PhylomeDB; P40739; -.
DR   BioCyc; BSUB:BSU39270-MON; -.
DR   Proteomes; UP000001570; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008982; F:protein-N(PI)-phosphohistidine-sugar phosphotransferase activity; IEA:InterPro.
DR   GO; GO:0090563; F:protein-phosphocysteine-sugar phosphotransferase activity; IBA:GO_Central.
DR   GO; GO:0090589; F:protein-phosphocysteine-trehalose phosphotransferase system transporter activity; IBA:GO_Central.
DR   GO; GO:0009401; P:phosphoenolpyruvate-dependent sugar phosphotransferase system; IBA:GO_Central.
DR   GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW.
DR   GO; GO:0015771; P:trehalose transport; IBA:GO_Central.
DR   CDD; cd00212; PTS_IIB_glc; 1.
DR   Gene3D; 2.70.70.10; -; 1.
DR   Gene3D; 3.30.1360.60; -; 1.
DR   InterPro; IPR011055; Dup_hybrid_motif.
DR   InterPro; IPR036878; Glu_permease_IIB.
DR   InterPro; IPR018113; PTrfase_EIIB_Cys.
DR   InterPro; IPR001127; PTS_EIIA_1_perm.
DR   InterPro; IPR003352; PTS_EIIC.
DR   InterPro; IPR013013; PTS_EIIC_1.
DR   InterPro; IPR011297; PTS_IIABC_b_glu.
DR   InterPro; IPR001996; PTS_IIB_1.
DR   Pfam; PF00358; PTS_EIIA_1; 1.
DR   Pfam; PF00367; PTS_EIIB; 1.
DR   Pfam; PF02378; PTS_EIIC; 1.
DR   SUPFAM; SSF51261; SSF51261; 1.
DR   SUPFAM; SSF55604; SSF55604; 1.
DR   TIGRFAMs; TIGR00830; PTBA; 1.
DR   TIGRFAMs; TIGR01995; PTS-II-ABC-beta; 1.
DR   PROSITE; PS51093; PTS_EIIA_TYPE_1; 1.
DR   PROSITE; PS00371; PTS_EIIA_TYPE_1_HIS; 1.
DR   PROSITE; PS51098; PTS_EIIB_TYPE_1; 1.
DR   PROSITE; PS01035; PTS_EIIB_TYPE_1_CYS; 1.
DR   PROSITE; PS51103; PTS_EIIC_TYPE_1; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Kinase; Membrane; Phosphotransferase system;
KW   Reference proteome; Sugar transport; Transferase; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..609
FT                   /note="PTS system beta-glucoside-specific EIIBCA component"
FT                   /id="PRO_0000186480"
FT   TRANSMEM        112..132
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00426"
FT   TRANSMEM        141..161
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00426"
FT   TRANSMEM        174..194
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00426"
FT   TRANSMEM        202..222
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00426"
FT   TRANSMEM        246..266
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00426"
FT   TRANSMEM        281..301
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00426"
FT   TRANSMEM        321..341
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00426"
FT   TRANSMEM        351..371
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00426"
FT   TRANSMEM        379..399
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00426"
FT   TRANSMEM        412..432
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00426"
FT   DOMAIN          1..86
FT                   /note="PTS EIIB type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00421"
FT   DOMAIN          103..459
FT                   /note="PTS EIIC type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00426"
FT   DOMAIN          480..584
FT                   /note="PTS EIIA type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00416"
FT   ACT_SITE        26
FT                   /note="Phosphocysteine intermediate; for EIIB activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00421"
FT   ACT_SITE        532
FT                   /note="Tele-phosphohistidine intermediate; for EIIA
FT                   activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00416"
FT   CONFLICT        75
FT                   /note="A -> S (in Ref. 5; CAA59697)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        288
FT                   /note="L -> F (in Ref. 2; BAA06652/BAA06256)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        434
FT                   /note="G -> E (in Ref. 1; CAA84286)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        436
FT                   /note="A -> S (in Ref. 2; BAA06652/BAA06256)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        449..450
FT                   /note="DG -> HR (in Ref. 2; BAA06652/BAA06256)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        549
FT                   /note="I -> M (in Ref. 2; BAA06652/BAA06256)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        552
FT                   /note="G -> S (in Ref. 2; BAA06652/BAA06256)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   609 AA;  64478 MW;  C2D45B33C5C2765A CRC64;
     MDYDKLSKDI LQLVGGEENV QRVIHCMTRL RFNLHDNAKA DRSQLEQLPG VMGTNISGEQ
     FQIIIGNDVP KVYQAIVRHS NLSDEKSAGS SSQKKNVLSA VFDVISGVFT PILPAIAGAG
     MIKGLVALAV TFGWMAEKSQ VHVILTAVGD GAFYFLPLLL AMSAARKFGS NPYVAAAIAA
     AILHPDLTAL LGAGKPISFI GLPVTAATYS STVIPILLSI WIASYVEKWI DRFTHASLKL
     IVVPTFTLLI VVPLTLITVG PLGAILGEYL SSGVNYLFDH AGLVAMILLA GTFSLIIMTG
     MHYAFVPIMI NNIAQNGHDY LLPAMFLANM GQAGASFAVF LRSRNKKFKS LALTTSITAL
     MGITEPAMYG VNMRLKKPFA AALIGGAAGG AFYGMTGVAS YIVGGNAGLP SIPVFIGPTF
     IYAMIGLVIA FAAGTAAAYL LGFEDVPSDG SQQPAVHEGS REIIHSPIKG EVKALSEVKD
     GVFSAGVMGK GFAIEPEEGE VVSPVRGSVT TIFKTKHAIG ITSDQGAEIL IHIGLDTVKL
     EGQWFTAHIK EGDKVAPGDP LVSFDLEQIK AAGYDVITPV IVTNTDQYSF SPVKEIGKVQ
     PKEALLALS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024